Based on these findings, it appears a worthwhile goal to evaluate the efficacy of anti-TGF-β therapy to treat radiotherapy-induced ionising radiation injury or to rejuvenate neurogenesis in aged individuals who exhibit cognitive decline. This evidence concerns the gene TGFB1 and Mental deterioration.